Koers Yield10 Bioscience Inc Nasdaq
Aandelen
US98585K1025
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 2,25 mln. 2,07 mln. | Omzet 2025 * | 4 mln. 3,68 mln. | Marktkapitalisatie | 1,36 mln. 1,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -11 mln. -10,12 mln. | Nettowinst (verlies) 2025 * | -13 mln. -11,96 mln. | EV/omzet 2024 * | 0,6 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,34 x |
K/w-verhouding 2024 * |
-0,12
x | K/w-verhouding 2025 * |
-0,1
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Yield10 Bioscience Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 01-06-92 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 01-01-08 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-01-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 01-10-06 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 02-03-17 |
Oliver Peoples
FOU | Founder | 66 | 01-06-92 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,85 mld. | |
-0,09% | 42,82 mld. | |
+49,62% | 42,03 mld. | |
-4,96% | 29,55 mld. | |
+11,18% | 26,11 mld. | |
-21,95% | 19,13 mld. | |
+8,61% | 13,05 mld. | |
+28,31% | 12,16 mld. | |
+24,73% | 12,08 mld. |